A viable alternative to classical media supplemented with 10% FBS is reduced-serum media formulations. These formulations of classical media types, such as DMEM and RPMI, are nutritionally enhanced using the natural components of serum, including lipids, growth factors and proteins, which allow the use of serum to be reduced as low as 2% depending on cell type. Additionally, the reduced serum content in a user’s media helps to reduce any variability in their cell culture due to variability in serum batches, enabling a more flexible process.
The HyClone range of reduced-serum media, along with the full HyClone portfolio of media, serum, buffers and process supplements, is distributed in Australia by In Vitro Technologies. The company provides full product support for the range including serum batch testing support and media customisation.
Phone: 03 9771 3700
Cayman Chemical Kinase Screening Library (96-Well)
Cayman Chemical's Kinase Screening Library (96-Well) consists of two plates and contains...
AdipoGen Life Sciences GLP-1, GIP and GCG receptor agonists
AdipoGen's range of GLP-1, GIP and GCG receptor agonists includes Liraglutide, Retatrutide,...
Integrated DNA Technologies xGen Hybridization and Wash v3 Kit
Integrated DNA Technologies (IDT) has unveiled its xGen Hybridization and Wash v3 Kit — a...
